Cybin Awarded Notice of Allowance from U.S. Patent and Trademark Office for CYB004 (Deuterated Psychedelic Tryptamine)… Dec 15, 2021
PharmaDrug Advances Psychedelics Program with Analogue DMT Formulations to Treat Eye Diseases Nov 5, 2021
Small Pharma CEO On Innovative Passport Designation, Patents & More As Psychedelic Stock Surges Nov 1, 2021